Search Results 321-330 of 8519 for Apixaban

  1. Orlistat (oral route) - Side effects & dosage - Mayo Clinic

    Drug Interactions · Abacavir · Acenocoumarol · Acetazolamide · Acetazolamide Sodium · Acetohexamide · Apixaban · Ardeparin · Argatroban ...

  2. Lusutrombopag (oral route) - Mayo Clinic

    Lusutrombopag is used to treat thrombocytopenia (low platelets in the blood) in adults with chronic liver disease who are scheduled to have a medical or dental ...

  3. Ivabradine (oral route) - Mayo Clinic

    Description. Ivabradine is used to treat adults who have chronic heart failure to reduce their risk of hospitalization for worsening heart failure.

  4. Post Operative Adjuvant Therapy De-intensification Trial For Human Papillomavirus-related, P16+ Oropharynx Cancer - Mayo Clinic

    About this study. This randomized clinical trial studies the intensity of adjuvant ("helper") therapy required in p16 positive oropharynx cancer patients, ...

  5. Enoxaparin (intravenous route, subcutaneous route, injection route) - Side effects & dosage - Mayo Clinic

    Apixaban; Argatroban; Aspirin; Bemiparin; Betrixaban; Bivalirudin; Bromfenac; Bufexamac; Caplacizumab-yhdp; Celecoxib; Choline Salicylate; Citalopram; Clonixin ...

  6. Empagliflozin and linagliptin (oral route) - Side effects & dosage - Mayo Clinic

    Empagliflozin and linagliptin combination is used together with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes. It is also ...

  7. Gemcitabine, Cisplatin, And Abraxane In Advanced Biliary Cancers - Mayo Clinic

    The goal of this clinical research study is to learn if adding abraxane (nab-paclitaxel) to gemcitabine and cisplatin can help to control metastatic or ...

  8. Cabozantinib (oral route) - Mayo Clinic

    Cabozantinib capsule is used to treat medullary thyroid cancer that has already spread to different parts of the body. Cabozantinib tablet is used alone to ...

  9. A Study Of ATV-1601 In Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

    Participants who require full-dose therapeutic anticoagulation (eg, vitamin K antagonists, heparin, dabigatran, rivaroxaban, apixaban) or high-dose antiplatelet ...

  10. Study Of Sacituzumab Govitecan-hziy And Pembrolizumab Versus Treatment Of Physician's Choice In Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery And Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) - Mayo Clinic

    Study Of Sacituzumab Govitecan-hziy And Pembrolizumab Versus Treatment Of Physician's Choice In Patients With Triple Negative Breast Cancer Who Have ...